ES2056173T3 - Analisis de lipoproteina en sangre por resonancia magnetica nuclear. - Google Patents
Analisis de lipoproteina en sangre por resonancia magnetica nuclear.Info
- Publication number
- ES2056173T3 ES2056173T3 ES89116979T ES89116979T ES2056173T3 ES 2056173 T3 ES2056173 T3 ES 2056173T3 ES 89116979 T ES89116979 T ES 89116979T ES 89116979 T ES89116979 T ES 89116979T ES 2056173 T3 ES2056173 T3 ES 2056173T3
- Authority
- ES
- Spain
- Prior art keywords
- magnetic resonance
- nuclear magnetic
- blood lipoprotein
- lipoprotein analysis
- analysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004895 Lipoproteins Human genes 0.000 title abstract 3
- 108090001030 Lipoproteins Proteins 0.000 title abstract 3
- 238000004458 analytical method Methods 0.000 title abstract 2
- 238000005481 NMR spectroscopy Methods 0.000 title 1
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 238000001228 spectrum Methods 0.000 abstract 3
- 210000002381 plasma Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/92—Computer assisted medical diagnostics
- Y10S128/922—Computer assisted medical diagnostics including image analysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- High Energy & Nuclear Physics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Abstract
METODO Y APARATO PARA DETERMINAR, EN UN ANALISIS DE PLASMA SANGUINEO, LA CONCENTRACION DE LOS COMPONENETES DE LIPOPROTEINA, VLDL, LDL, HDL Y PROTEINAS INCLUIDAS, OBTENIDA POR EL MOVIMIENTO DEL ESPECTRO QUIMICO DEL NMR DE UNA MUESTRA. TOMANDO COMO REFERENCIA EL ESPECTRO NMR DE LA LIPOPROTEINA Y LOS COMPONENTES SE JUNTAN PARA FORMAR UNA LINEA DE DESARROLLO QUE MIDA EL REGISTRO SUPERIOR DEL ESPECTRO NMR DEL PLASMA SANGUINEO, Y DESPUES DE ESTO QUEDA DETERMINADA LA CONCENTRACION DE CADA LIPOPROTEINA Y CONSTITUYENTES EN EL PLASMA SANGUINEO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/248,750 US4933844A (en) | 1988-09-26 | 1988-09-26 | Measurement of blood lipoprotein constituents by analysis of data acquired from an NMR spectrometer |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2056173T3 true ES2056173T3 (es) | 1994-10-01 |
Family
ID=22940515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89116979T Expired - Lifetime ES2056173T3 (es) | 1988-09-26 | 1989-09-13 | Analisis de lipoproteina en sangre por resonancia magnetica nuclear. |
Country Status (6)
Country | Link |
---|---|
US (1) | US4933844A (es) |
EP (1) | EP0361214B1 (es) |
JP (1) | JP3059181B2 (es) |
CA (1) | CA1327993C (es) |
DE (1) | DE68916729T2 (es) |
ES (1) | ES2056173T3 (es) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05500918A (ja) * | 1989-10-06 | 1993-02-25 | ザ ベス イスラエル ホスピタル アソシエイション | ガン発見のためのnmr装置と方法 |
US5366440A (en) * | 1989-10-06 | 1994-11-22 | The Beth Israel Hospital Association | Methods for treating disease states using oxidized lipoproteins in conjunction with chemotherapeutic effector agents |
US5192264A (en) * | 1989-10-06 | 1993-03-09 | The Beth Israel Hospital Association | Methods and apparatus for treating disease states using oxidized lipoproteins |
CA2071638A1 (en) * | 1989-12-21 | 1991-06-22 | Eric T. Fossel | Method for predicting atherosclerotic risk |
SE9001698L (sv) * | 1990-05-10 | 1991-11-11 | Chiscan Ab | En metod foer att upptaecka maligniteter |
US5207715A (en) * | 1990-07-24 | 1993-05-04 | The Beth Israel Hospital Association | Method of detecting cancer by measuring lipid-peroxidation using NMR |
AU2384292A (en) * | 1991-07-30 | 1993-03-02 | North Carolina State University | Method and apparatus for measuring blood lipoprotein levels by nmr spectroscopy |
WO1993021517A1 (en) * | 1992-04-10 | 1993-10-28 | The Beth Israel Hospital Association | Measurement of propensity to atherosclerosis; oxidizability of olefinic residues of plasma lipoproteins and lipids |
WO1994007146A1 (en) * | 1992-09-24 | 1994-03-31 | Perseptive Biosystems, Inc. | Quantitative measurement of ldl |
US6104191A (en) * | 1998-03-17 | 2000-08-15 | General Electric Company | Quantitative in vivo spectroscopy using oversampling, waterline referencing, and prior knowledge fitting |
US6653140B2 (en) | 1999-02-26 | 2003-11-25 | Liposcience, Inc. | Methods for providing personalized lipoprotein-based risk assessments |
WO2000051054A1 (en) | 1999-02-26 | 2000-08-31 | Lipomed, Inc. | Methods, systems, and computer program products for analyzing and presenting risk assessment results based on nmr lipoprotein analysis of blood |
US6518069B1 (en) | 1999-04-22 | 2003-02-11 | Liposcience, Inc. | Methods and computer program products for determining risk of developing type 2 diabetes and other insulin resistance related disorders |
CA2331116A1 (en) * | 2001-01-15 | 2002-07-15 | Chenomx, Inc. | Compound identification and quantitation in liquid mixtures -- method and process using an automated nuclear magnetic resonance measurement system |
GB2410559B (en) * | 2001-01-15 | 2005-09-28 | Chenomx Inc | Process, apparatus, media and signals for automatically identifying compounds in a sample |
US20030028093A1 (en) * | 2001-04-20 | 2003-02-06 | Yong Ke | Exponential decay modeling in spectroscopy |
WO2003012416A1 (en) * | 2001-08-01 | 2003-02-13 | Liposcience, Inc. | Method of determining presence and concentration of lipoprotein x in blood plasma and serum |
US7259018B2 (en) * | 2001-11-13 | 2007-08-21 | The Regents Of The University Of California | Ion mobility analysis of lipoproteins |
AU2003285926A1 (en) * | 2002-10-25 | 2004-05-25 | Liposcience, Inc. | Methods, systems and computer programs for deconvolving the spectral contribution of chemical constituents with overlapping signals |
JP2007511749A (ja) * | 2003-10-23 | 2007-05-10 | リポサイエンス,インコーポレイテッド | 個別サイズのldl(低比重リポ蛋白)サブクラス粒子の生体内での濃度勾配を考慮する数理モデルを使用してchd(冠状動脈性心臓疾患)のリスクを評価する方法、システムおよびコンピュータプログラム |
US8013602B2 (en) * | 2004-04-01 | 2011-09-06 | Liposcience, Inc. | NMR clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples |
US7064544B1 (en) * | 2004-05-18 | 2006-06-20 | General Electric Company | Method and system of scaling MR spectroscopic data acquired with phased-array coils |
DE102004026903B4 (de) * | 2004-06-01 | 2006-05-18 | Universität Regensburg | Verfahren zur Bestimmung von Lipoproteinen in Körperflüssigkeiten und Messanordnung dafür |
US20070207516A1 (en) * | 2005-12-21 | 2007-09-06 | Doupe Thomas H | Cholesterol measurement system and method |
WO2007133593A2 (en) * | 2006-05-10 | 2007-11-22 | Liposcience, Inc. | Methods, systems and computer programs for assessing chd risk using weighted hdl particle number measurements |
US8247235B2 (en) | 2007-06-08 | 2012-08-21 | Quest Diagnostics Investments Incorporated | Lipoprotein analysis by differential charged-particle mobility |
US20080302666A1 (en) * | 2007-06-08 | 2008-12-11 | Benner W Henry | Apparatus for differential charged-particle mobility |
US9354200B1 (en) | 2008-08-07 | 2016-05-31 | Quest Diagnostics Investments Incorporated | Detection apparatus for differential-charged particle mobility analyzer |
AU2009308124B2 (en) * | 2008-10-20 | 2014-12-11 | Liposcience, Inc. | Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same |
DE102009026651A1 (de) | 2009-06-02 | 2011-02-17 | Großmann, Kay, Dr. rer. nat. (Chemie) | Verfahren und Messvorrichtung zur qualitativen und quantitativen Analyse von Körperflüssigkeiten |
EP2270530B1 (en) * | 2009-07-01 | 2013-05-01 | Københavns Universitet | Method for prediction of lipoprotein content from NMR data |
WO2011011267A1 (en) | 2009-07-22 | 2011-01-27 | Eli Lilly And Company | Method for predicting weight gain associated with a pharmaceutical therapy |
US9250211B2 (en) | 2010-12-30 | 2016-02-02 | Quest Diagnostics Investments Incorporated | Magnetic separation of lipoproteins using dextran sulfate |
US9483612B2 (en) | 2012-04-27 | 2016-11-01 | Liposcience, Inc. | CHD risk stratification evaluations for subjects with high levels of large HDL-P |
US9470771B2 (en) | 2012-06-08 | 2016-10-18 | Liposcience, Inc. | NMR measurements of NMR biomarker GlycA |
US9361429B2 (en) | 2012-06-08 | 2016-06-07 | Liposcience, Inc. | Multi-parameter diabetes risk evaluations |
US9928345B2 (en) | 2012-06-08 | 2018-03-27 | Liposciences, Inc. | Multiple-marker risk parameters predictive of conversion to diabetes |
WO2014059025A1 (en) | 2012-10-09 | 2014-04-17 | Liposcience, Inc. | Nmr quantification of branched chain amino acids |
US9551768B2 (en) | 2013-03-15 | 2017-01-24 | East Carolina University | NMR method for monitoring changes in the core of lipoprotein particles in metabolism and disease |
US20150260631A1 (en) * | 2014-03-17 | 2015-09-17 | Health Diagnostic Laboratory, Inc. | System and method for assessing quanitites or sizes of lipoprotein particles from lipoprotein particle compositions |
EP3021874B1 (en) * | 2013-07-18 | 2022-04-27 | The University of Hong Kong | Methods for classifying pleural fluid |
DK3074775T3 (en) * | 2013-11-27 | 2018-10-01 | Inst Dinvestigacio Sanitaria Pere Virgili | Method for characterizing lipoproteins |
US9952232B2 (en) | 2014-09-11 | 2018-04-24 | Liposcience, Inc. | Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter |
EP3258285B1 (en) | 2016-06-14 | 2020-10-21 | Bruker BioSpin GmbH | Method for predicting chemical shift values of nmr spin systems in a sample of a fluid class, in particular in a sample of a biofluid |
DE102016224691A1 (de) | 2016-12-12 | 2018-06-14 | Numares Ag | Verfahren zur Analyse eines NMR-Spektrums einer lipoproteinhaltigen Probe |
WO2019051226A1 (en) * | 2017-09-07 | 2019-03-14 | Liposcience, Inc. | METABOLIC VULNERABILITY INDEX ASSESSMENTS WITH MULTIPLE PARAMETERS |
US11467171B2 (en) | 2017-11-10 | 2022-10-11 | Liposcience, Inc. | Methods and systems to detect and quantify the amount of LP-X and other abnormal lipoproteins in a biosample using NMR spectroscopy |
EP3877767A1 (en) | 2018-11-08 | 2021-09-15 | Liposcience, Inc. | Methods to predict liver disease mortality using lipoprotein lp-z |
DE102023110285B3 (de) | 2023-04-21 | 2024-05-08 | Universität zu Lübeck, Körperschaft des öffentlichen Rechts | Nmr-messung von glykoproteinen |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US28803A (en) * | 1860-06-19 | Coffee-pot | ||
USRE28803E (en) | 1971-09-09 | 1976-05-04 | American Monitor Corporation | Method and electronic control for the analyzation of serum chemistries |
US3950135A (en) * | 1974-07-24 | 1976-04-13 | Massachusetts Institute Of Technology | Method of sepctral analysis using nmr shift reagents |
US4224031A (en) * | 1977-11-15 | 1980-09-23 | Mee John M L | CI Mass spectrometric analysis of physiologically active compounds |
US4720788A (en) * | 1984-06-20 | 1988-01-19 | Helena Laboratories Corporation | Diagnostic densitometer |
GB8520587D0 (en) * | 1985-08-16 | 1985-09-25 | Picker Int Ltd | Spectroscopy method |
IL81276A (en) * | 1986-02-26 | 1991-05-12 | Beth Israel Hospital | Process for the screening of cancer using nuclear magnetic resonance spectroscopy |
DE3617161A1 (de) * | 1986-05-22 | 1987-11-26 | Boehringer Mannheim Gmbh | System zur bestimmung der konzentration von bestandteilen von koerperfluessigkeiten |
-
1988
- 1988-09-26 US US07/248,750 patent/US4933844A/en not_active Expired - Lifetime
-
1989
- 1989-09-13 DE DE68916729T patent/DE68916729T2/de not_active Expired - Lifetime
- 1989-09-13 EP EP89116979A patent/EP0361214B1/en not_active Expired - Lifetime
- 1989-09-13 ES ES89116979T patent/ES2056173T3/es not_active Expired - Lifetime
- 1989-09-20 JP JP1246216A patent/JP3059181B2/ja not_active Expired - Lifetime
- 1989-09-22 CA CA000612578A patent/CA1327993C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE68916729T2 (de) | 1994-12-08 |
US4933844A (en) | 1990-06-12 |
CA1327993C (en) | 1994-03-22 |
EP0361214B1 (en) | 1994-07-13 |
JP3059181B2 (ja) | 2000-07-04 |
DE68916729D1 (de) | 1994-08-18 |
JPH02116743A (ja) | 1990-05-01 |
EP0361214A1 (en) | 1990-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2056173T3 (es) | Analisis de lipoproteina en sangre por resonancia magnetica nuclear. | |
Anderson et al. | Analysis and testing of adhesive bonds | |
ES2130202T3 (es) | Dispositivo y procedimiento para ensayar colesterol hdl en sangre completa. | |
ES2086230T3 (es) | Metodo para mejorar la precision de las mediciones en ensayos con biosensores opticos de ondas evanescentes. | |
ES2112057T3 (es) | Metodo de deteccion y/o cuantificacion y/o separacion de celulas apoptosicas dentro de o en una muestra. | |
KR900700620A (ko) | 전류적 정진단 분석방법 및 장치 | |
ES2042987T3 (es) | Metodo y aparato de investigar constituyentes de la orina. | |
SE8701054D0 (sv) | Magnetic resonance analysis of substances in samples that include dissipative material | |
DK314580A (da) | Elektrodeapparatur til bestemmelse af gaskoncentration i blod | |
ES2050683T3 (es) | Analizador optico de gas. | |
DK111088D0 (da) | Fremgangsmaade og apparat til maaling af substanskoncentrationer i en legemsvaeske ved optoakustisk spektroskopi | |
SE8000472L (sv) | Forfarande och anordning for pavisande av spenningar i ett foremal | |
IT8067149A0 (it) | Ro procedimento e dispositivo per analisi di campioni di sangue inte | |
ES2152578T3 (es) | Indices identificadores para bases de datos. | |
SE7708351L (sv) | Optodanordning | |
ES2115584T3 (es) | Antigeno sintetico para la deteccion de enfermedades referentes al sida. | |
DE69010704D1 (de) | Verfahren zur Untersuchung von Relaxationsspektren und Resonanzen in Materialien. | |
ES2038594T3 (es) | Analisis de fluidos por medio del uso de una fuente de neutrones rapidos. | |
ATE294962T1 (de) | Industrielle online-analyse mittels kernspinresonanzspektroskopie | |
IT7968578A0 (it) | Dispositivo e procedimento per la determinazione della concentrazione di un costituente in un campione per via cromatografica e ottica | |
SE8800767L (sv) | Nmr-apparat foer undersoekning av en kropp, saerskilt foer avbildning av maenniskokroppens hud, och anordning foer alstring av en magnetfaeltsgradient i en saadan apparat | |
FI864286A (fi) | Foerfarande och anordning foer bestaemning av antibodyhalten i blod. | |
SE7706471L (sv) | Forfarande och anordning for magnetisk provning av material | |
ES2175123T3 (es) | Procedimiento que sirve para determinar la concentracion de oxigeno enuna muestra. | |
Muskiet et al. | CORRELATIONS BETWEEN A FLUORIMETRIC and MASS FRAGMENTOGRAPHIC METHOD FOR THE DETERMINATION OF 3‐METHOXY‐4‐HYDROXYPHENYLACETIC ACID and TWO MASS FRAGMENTOGRAPHIC METHODS FOR THE DETERMINATION OF 3‐METHOXY‐4‐HYDROXYPHENYLETHYLENE GLYCOL IN CEREBROSPINAL FLUID |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 361214 Country of ref document: ES |